Timothy J. Barberich - 20 Jul 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Timothy J Barberich
Issuer symbol
TCRX
Transactions as of
20 Jul 2021
Net transactions value
$0
Form type
4
Filing time
22 Jul 2021, 07:43:15 UTC
Previous filing
15 Jul 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Voting Common Stock Conversion of derivative security +33,259 33,259 20 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Series B Preferred Stock Conversion of derivative security -33,259 -100% 0 20 Jul 2021 Voting Common Stock 33,259 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.